Featuring speakers Rachel King, Chief Executive Officer for GlycoMimetics and Michael Richman, President and Chief Executive Officer for Amplimmune.

Hear from the CEOs of each company about why being homegrown and staying in Maryland is a key ingredient to success and what their achievements through IPO and acquisition can mean for your company and our life science community as a whole.

Fees:

TCM Member Plus: $50
TCM Members: $60
Non Members: $90